Therapy options for psoriasis in childhood and adolescence;Therapieoptionen der psoriasis im kindes- und jugendalter

JDDG - Journal of the German Society of Dermatology

Volumn 2, Issue 5, 2004, Pages 329-342

  Zappel, Kristina ^a   Sterry, Wolfram ^a   Blume Peytavi, Ulrike ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adolescence; Childhood; Psoriasis; Review; Therapy; Treatment

Indexed keywords

ABITIMA; ANTHELIOS S; ANTIBIOTIC AGENT; ANTIPSORIASIS AGENT; AVENE; BENZOYL PEROXIDE; BERNITER; CALCINEURIN INHIBITOR; CALCIPOTRIOL; CALCITRIOL; COAL TAR; COLECALCIFEROL DERIVATIVE; CORTICOSTEROID; CYCLOSPORIN A; DAPSON FATOL; DAYLONG KIDS; DITHRANOL; ERYTHROMYCIN; ETRETIN; EUCERIN OMEGA; HERMAL OLBAD; IMMUNOSPORIN; LANOLIN ALCOHOL; LINOLA; LIPOLOTIO; LYGAL; METHOTREXATE; METHYLPREDNISOLONE ACEPONATE; MOMETASONE FUROATE; MONOCLONAL ANTIBODY; NUBRAL; NYSTADERM; NYSTATIN; PENICILLIN DERIVATIVE; PETROLATUM; POLIDOCANOL; PSORALEN; PSORALON; RECOMBINANT PROTEIN; RIFAMPICIN; TACALCITOL; TARMED; TAZAROTENE; TEER LINOLA FETT; UNCLASSIFIED DRUG; UNINDEXED DRUG; UREA;

ADOLESCENT; AGE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; HUMAN; MYCODERM; OLBAD CORDES; PHYSICAL DEVELOPMENT; PRACTICE GUIDELINE; PROGNOSIS; PSORIASIS; PUVA; QUALITY OF LIFE; REVIEW; SKIN IRRITATION; SOCIAL ASPECT; STANDARD; SYMPTOM; TREATMENT INDICATION;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; DERMATOLOGIC AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; PSORIASIS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 2642520684     PISSN: 16100379     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0353.2004.04061.x     Document Type: Review

References (61)

1. Christophers E, Mrowietz U, Sterry W: Psoriasis - Auf einen Blick, 1. Auflage, Thieme, 2002.
2. Schachner LA, Hansen RC: Pediatric Dermatology, 3. Auflage, Leinen, Mosby, New York, Edinburgh, London, Melbourne, San Francisco, Tokyo, 1995.
3. Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol 2000; 17: 174-178.
4. Traupe H, Hamm H: Pädiatrische Dermatologie, 1. Auflage, Springer Verlag, Heidelberg, 1999.
5. Morris A, Rogers M, Fischer G, Williams K. Childhood psoriasis: a clinical review of 1262 cases. Pediatr Dermatol 2001; 18: 188-198.
6. Nanda A, Kaur S, Kaur I, Kumar B. Childhood psoriasis: an epidemiologic survey of 112 patients. Pediatr Dermatol 1990; 7: 19-21.
7. Oranje AP, Marcoux D, Svensson A, Prendiville J, Krafchik B, Toole J, Rosenthal D, de Waard-van der Spek FB, Molin L, Axelsen M. Topical calcipotriol in childhood psoriasis. J Am Acad Dermatol 1997; 36: 203-208.
8. Saggese G, Federico G, Battini R. Topical application of 1,25-dihydroxyvitamin D3 (calcitriol) is an effective and reliable therapy to cure skin lesions in psoriatic children. Eur J Pediatr 1993; 152: 389-392.
9. Burden AD. Management of psoriasis in childhood. Clin Exp Dermatol 1999; 24: 341-345.
10. Rogers M. Childhood psoriasis. Curr Opin Pediatr 2002; 14: 404-409.
11. Kravchenko I, Maibach H. Percutaneous Penetration. In: Hoath M, Maibach H. Neonatal Skin: Structure and Function. New York: Marcel Dekker, 2003: 285-298.
12. Chiou YB, Blume-Peytavi U. Stratum corneum maturation. A review of neonatal skin function. Skin Pharmacol Physiol 2004; 17: 57-66.
13. Siegfried E, Shah P. Neonatal skin and skin care. Dermatol Clin 1998; 16: 437-446.
14. Lewis-Jones MS, Finlay AY. Children's dermatology life quality index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132: 942-949.
15. Farber EM. Total care of psoriasis. Cutis 2000; 66: 318.
16. Orfanos CE, Garbe C: Therapie der Hautkrankheiten, 2. Auflage, Springer Verlag, Heidelberg, 2001.
17. Harper J, Oranje AP, Prose N: Textbook of Pediatric Dermatology, 2. Auflage, Blackwell, 2000.
18. Zvulunov A, Anisfeld A, Metzker A. Efficacy of short-contact therapy with dithranol in childhood psoriasis. Int J Dermatol 1994; 33: 808-810.
19. Perez A, Chen TC, Turner A, Holick MF. Pilot study of topical calcitriol (1,25-dihydroxyvitamin D3) for treating psoriasis in children. Arch Dermatol 1995; 131: 961-962.
20. Darley CR, Cunliffe WJ, Green CM, Hutchinson PE, Klaber MR, Downes N. Safety and efficacy of calcipotriol ointment (Dovonex) in treating children with psoriasis vulgaris. Br J Dermatol 1996; 135: 390-393.
21. Park SB, Suh DH, Youn JI. A pilot study to assess the safety and efficacy of topical calcipotriol treatment in childhood psoriasis. Pediatr Dermatol 1999; 16: 321-325.
22. Patrizi A, Neri I, Rizzoli L, Varotti C. Topical calcipotriol in childhood psoriasis. Acta Derm Venereol 1999; 79: 477.
23. Lebwohl M, Ast E, Callen JP, Cullen SI, Hong SR, Kulp-Shorten CL, Lowe NJ, Phillips TJ, Rosen T, Wolf DI, Quell JM, Sefton J, Lue JC, Gibson JR, Chandraratna RA. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. J Am Acad Dermatol 1998; 38: 705-711.
24. Meffert H, Piazena H, Sterry W. Indikationen und Risiken der UV-Therapie im Kindesalter. Pädiatr Grenzgeb 2000; 39: 325-336.
25. Honigsmann H. Phototherapy for psoriasis. Clin Exp Dermatol 2001; 26: 343-350.
26. Dawe RS, Cameron H, Yule S, Man I, Wainwright NJ, Ibbotson SH, Ferguson J. A randomized controlled trial of narrowband ultraviolet B versus bath-psoralen plus ultraviolet A photochemotherapy for psoriasis. Br J Dermatol 2003; 148: 1194-1204.
27. Cm P, A I I, BJ J. Cyclosporin in childhood psoriasis. J Dermatolog Treat 2003; 14: 113-118.
28. Kilic SS, Hacimustafaoglu M, Celebi S, Karadeniz A, Ildirim I. Low dose cyclosporin A treatment in generalized pustular psoriasis. Pediatr Dermatol 2001; 18: 246-248.
29. Mahe E, Bodemer C, Pruszkowski A, Teillac-Hamel D, de Prost Y. Cyclosporine in childhood psoriasis. Arch Dermatol 2001; 137: 1532-1533.
30. Cooney GF, Habucky K, Hoppu K. Cyclosporin pharmacokinetics in paediatric transplant recipients. Clin Pharmacokinet 1997; 32: 481-495.
31. Mrowietz U. Guidelines for cyclosporin therapy in dermatology. Issued by the Consensus Conference on Cyclosporins. Hautarzt 2001; 52: 201-204.
32. Gollnick HPM, Dümmler U. Retinoids. Clin Dermatol 1997; 15: 799-810.
33. Li SP, Tang WY, Lam WY, Wong SN. Renal failure and cholestatic jaundice as unusual complications of childhood pustular psoriasis. Br J Dermatol 2000; 143: 1292-1296.
34. Murray HE, Anhalt AW, Lessard R, Schacter RK, Ross JB, Stewart WD, Geiger JM. A 12-month treatment of severe psoriasis with acitretin: results of a Canadian open multicenter study. J Am Acad Dermatol 1991; 24: 598-602.
35. Ruiz-Maldonado R, Tamayo-Sanchez L, de La Luz Orozco-Covarrubias M. The use of retinoids in pediatric patients. Pediatr Dermatol 1998; 16: 553-569.
36. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol 2003; 49: 171-186.
37. Kumar B, Dhar S, Handa S, Kaur I. Methotrexate in childhood psoriasis. Pediatr Dermatol 1994; 11: 271-273.
38. Zachariae H, Heickendorff L, Sogaard H. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up. Br J Dermatol 2001; 144: 100-103.
39. Vainionpaa L, Risteli L, Lanning M, Myllyla V, Risteli J. Aminoterminal propeptide of type III procollagen in cerebrospinal fluid. Variation with age and in childhood leukemia. Clin Chim Acta 1991; 203: 47-56.
40. Yu HJ, Park JW, Park JM, Hwang DK, Park YW. A case of childhood generalized pustular psoriasis treated with dapsone. J Dermatol 2001; 28: 316-319.
41. Telfer NR, Chalmers RJ, Whale K, Colman G. The role of streptococcal infection in the initiation of guttate psoriasis. Arch Dermatol 1992; 128: 39-42.
42. Valdimarsson H, Baker BS, Jonsdottir I, Powles A, Fry L. Psoriasis: a T-cell-mediated autoimmune disease induced by streptococcal superantigens? Immunol Today 1995; 16: 145-149.
43. Yarwood JM, Leung DY, Schlievert PM. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. FEMS Microbiol Lett 2000; 192: 1-7.
44. Leung DY, Travers JB, Norris DA. The role of superantigens in skin disease. J Invest Dermatol 1995; 105: 37S-42S.
45. Owen CM, Chalmers RJ, O'Sullivan T, Griffiths CE. A systematic review of antistreptococcal interventions for guttate and chronic plaque psoriasis. Br J Dermatol 2001; 145: 886-890.
46. Chalmers RR, O'Sullivan T, Owen CC, Griffiths CC. A systematic review of treatments for guttate psoriasis. Br J Dermatol 2001; 145: 891-894.
47. Chalmers RJ, O'Sullivan T, Owen CM, Griffiths CE. Interventions for guttate psoriasis. Cochrane Database Syst Rev 2000; CD001 213.
48. Owen CM, Chalmers RJ, O'Sullivan T, Griffiths CE. Antistreptococcal interventions for guttate and chronic plaque psoriasis. Cochrane Database Syst Rev 2000; CD001 976.
49. Vincent F, Ross JB, Dalton M, Wort AJ. A therapeutic trial of the use of penicillin V or erythromycin with or without rifampin in the treatment of psoriasis. J Am Acad Dermatol 1992; 26: 458-461.
50. Wilson JK, Al Suwaidan SN, Krowchuk D, Feldman SR. Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy? Pediatr Dermatol 2003; 20: 11-15.
51. Komine M, Tamaki K. An open trial of oral macrolide treatment for psoriasis vulgaris. J Dermatol 2000; 27: 508-512.
52. Rosenberg EW, Noah PW, Zanolli MD, Skinner RB, Jr, Bond MJ, Crutcher N. Use of rifampin with penicillin and erythromycin in the treatment of psoriasis. Preliminary report. J Am Acad Dermatol 1986; 14: 761-764.
53. Honig PJ. Guttate psoriasis associated with perianal streptococcal disease. J Pediatr 1988; 113: 1037-1039.
54. Nyfors A, Rasmussen PA, Lemholt K, Eriksen B. Improvement of refractory psoriasis vulgaris after tonsillectomy. Dermatologica 1975; 151: 216-222.
55. Hone SW, Donnelly MJ, Powell F, Blayney AW. Clearance of recalcitrant psoriasis after tonsillectomy. Clin Otolaryngol 1996; 21: 546-547.
56. Khoo BP, Giam YC. A pilot study on the role of intralesional triamcinolone acetonide in the treatment of pitted nails in children. Singapore Med J 2000; 41: 66-68.
57. Friedrich M, Sterry W, Asadullah K. Neue Entwicklungen in der systematischen Psoriasistherapie. JDDG 2003; 1: 12-21.
58. Werfel S, Boeck K, Abeck D, Ring J. Besonderheiten der topischen Therapie im Kindesalter. Hautarzt 1998; 49: 170-175.
59. Fond L, Michel JL, Gentil-Perret A, Eve B, Montelimard N, Perrot JL, Cambazard F. Psoriasis in childhood. Arch Pediatr 1999; 6: 669-674.
60. Freeman AK, Linowski GJ, Brady C, Lind L, Vanveldhuisen P, Singer G, Lebwohl M. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol 2003; 48: 564-568.
61. Gollnick HPM. Oral retinoids - efficacy and toxicity in psoriasis. Br J Dermatol 1996; 135 S 49: 6-17.